Nancy Chang
Biochemist • Engineer • BioPhysicist
Nancy Chang is one of the world's most successful biotech businesswomen. She co-founded Tanox in 1986 to address medical needs in the areas of allergy, asthma, inflammation and diseases affecting the human immune system. We had the amazing opportunity to work for her as we made a documentary about her significant contribution in the field of Science.
Tanox Company
Tanox, a company co-founded by Nancy Chang pioneered the use of humanized antibodies targeting the B cells involved in allergic asthma.The company also researches treatments for HIV, inflammation and diseases affecting the human immune system.
TNX-355
The Tanox company was also part of the development of TNX-355, an antibody for the treatment of HIV/AIDS. Dr. Nancy Chang grew Tanox from an idea to a substantial publicly-traded company, doing scientific innovations.
Xolair
Tanox focused on medical needs in allergy, asthma, and diseases affecting the human immune system. They have developed an asthma drug that targeted the allergy-related basis of asthma called Xolair. It’s the first FDA-approved biotech product cleared for treating asthma related to allergies.
Excerpt from my work with Nancy Chang and the Science History Institute.